Literature DB >> 21863278

Clinical practice and the development of evidence.

Bridget Wilcken.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 21863278     DOI: 10.1007/s10545-011-9380-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.

Authors:  Beth K Potter; Julian Little; Pranesh Chakraborty; Jonathan B Kronick; Jessica Evans; Julia Frei; Sarah C Sutherland; Kumanan Wilson; Brenda J Wilson
Journal:  J Inherit Metab Dis       Date:  2011-06-01       Impact factor: 4.982

2.  Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop.

Authors:  U Spiekerkoetter; M Lindner; R Santer; M Grotzke; M R Baumgartner; H Boehles; A Das; C Haase; J B Hennermann; D Karall; H de Klerk; I Knerr; H G Koch; B Plecko; W Röschinger; K O Schwab; D Scheible; F A Wijburg; J Zschocke; E Mayatepek; U Wendel
Journal:  J Inherit Metab Dis       Date:  2009-04-28       Impact factor: 4.982

Review 3.  Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.

Authors:  Ute Spiekerkoetter; Jean Bastin; Melanie Gillingham; Andrew Morris; Frits Wijburg; Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2010-09-10       Impact factor: 4.982

4.  Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a β-oxidation defect.

Authors:  Sara Tucci; Ulrich Flögel; Marga Sturm; Elena Borsch; Ute Spiekerkoetter
Journal:  Am J Clin Nutr       Date:  2011-06-22       Impact factor: 7.045

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.